Plantão e! Science News
06.09.2016

New HIF-2 kidney cancer therapy more effective than current treatment, study shows


A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.read more

Leia toda a matéria clicando aqui!
Source: esciencenews.com
  • IndiqueShare this page
  • CompartilharShare
  • You are recommending this story:
  • Fill in the following form to send your recommendation to your friend:

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.